---  
layout: startup_page  
title: "Epicrispr Biotechnologies"  
id: "epicrispr.com"  
permalink: "/epicrisprbiotechnologiesepicrispr.com03262025/"  
website: "https://epicrispr.com/"  
funding_round: "Series B"  
funding_amount: "$68M"  
investors: "Ally Bridge Group, SOLVE FSHD, Other investors"  
about: "Epicrispr Biotechnologies is a biotechnology company developing curative therapies, specifically focusing on gene-modulating therapies for neuromuscular diseases. Their lead program, EPI-321, is a first-in-class, disease-modifying therapy for facioscapulohumeral muscular dystrophy (FSHD), targeting the underlying genetic cause of the disease and aiming to silence aberrant gene expression."  
markets: "Biotech, Therapeutics, Gene Therapy"  
hq: "South San Francisco, California, United States"  
founded_year: "2018"  
linkedin: "https://www.linkedin.com/company/epicrispr-biotechnologies"  
twitter: "https://twitter.com/EpicrisprBio"  
instagram: ""  
facebook: "https://www.facebook.com/Epicbiotech"  
crunchbase: "https://www.crunchbase.com/organization/epic-bio"  
pitchbook: "https://pitchbook.com/profiles/company/501378-58"  

date_display: "26-Mar-2025"  
date: "2025-03-26"

# SEO Optimization  
meta_title: "Epicrispr Biotechnologies - Series B Funding ($68M)"  
meta_description: "Epicrispr Biotechnologies, Epicrispr Biotechnologies is a biotechnology company developing curative therapies, specifically focusing on gene-modulating therapies for neuromuscul..."  
meta_keywords: "Epicrispr Biotechnologies, Biotech, Therapeutics, Gene Therapy, Series B funding"  
canonical_url: "https://startup.projectstartups.com/epicrisprbiotechnologiesepicrispr.com03262025/"  
---